相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy
Jeffrey J. Leow et al.
EUROPEAN UROLOGY (2021)
The incidence and prevalence of upper tract urothelial carcinoma: a systematic review
Ahmed Soualhi et al.
BMC UROLOGY (2021)
Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer
Susan Tsai et al.
ANNALS OF SURGERY (2020)
CA19-9 for detecting recurrence of pancreatic cancer
Azadeh Azizian et al.
SCIENTIFIC REPORTS (2020)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases
Sunyoung Kim et al.
SCIENTIFIC REPORTS (2020)
Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China
Qingwei Wang et al.
BMC UROLOGY (2019)
Clinical staging of upper urinary tract urothelial carcinoma for T staging: Review and pictorial essay
Yukiko Honda et al.
INTERNATIONAL JOURNAL OF UROLOGY (2019)
Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis
Gian Carlo Mattiucci et al.
TRANSLATIONAL ONCOLOGY (2019)
High preoperative serum CA 19-9 levels can predict poor oncologic outcomes in colorectal cancer patients on propensity score analysis
Jung Kyong Shin et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2019)
Establishment of the Seoul National University Prospectively Enrolled Registry for Genitourinary Cancer (SUPER-GUC): A prospective, multidisciplinary, bio-bank linked cohort and research platform
Chang Wook Jeong et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2019)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer
Yanfeng Gao et al.
SCIENTIFIC REPORTS (2018)
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel
Thomas Seisen et al.
EUROPEAN UROLOGY (2016)
Serum CA 19-9 as a good prognostic biomarker in patients with bladder cancer
Qing-hai Wang et al.
INTERNATIONAL JOURNAL OF SURGERY (2015)
The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates
K. E. Poruk et al.
CURRENT MOLECULAR MEDICINE (2013)
CA 19-9 as a serum marker in urothelial carcinoma
Mahander Pall et al.
UROLOGY ANNALS (2012)
Clinical Usefulness of CEA, CA19-9, and CYFRA 21-1 as Tumor Markers for Urothelial Bladder Carcinoma
Satoshi Washino et al.
UROLOGIA INTERNATIONALIS (2011)
Gender-related Differences in Patients With Stage I to III Upper Tract Urothelial Carcinoma: Results From the Surveillance, Epidemiology, and End Results Database
Giovanni Lughezzani et al.
UROLOGY (2010)
CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions
Daniele Marrelli et al.
AMERICAN JOURNAL OF SURGERY (2009)
CA19-9 as a serum marker for poor prognosis in urothelial carcinoma
K Sashide et al.
UROLOGIA INTERNATIONALIS (2004)
分享论文
